QIACUITY
LIVE

Serial Number

79294827

Owner

QIAGEN GMBH

Attorney

G MATHEW LOMBARD

Filing Date

May 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

QIACUITY Trademark

Serial Number: 79294827 • Registration: 6458294

QIACUITY is a trademark filed by QIAGEN GMBH on May 20, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

May 20, 2020

Registration Date

August 24, 2021

Published for Opposition

June 8, 2021

Goods & Services

Scientific apparatus, instruments and equipment for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis and industrial use, in particular DNA and RNA testing apparatus, and accessories, namely, microplates, Society of Biomolecular Screening (SBS) standardized laboratory equipment in particular microplates, plate holders and plate seals, downloadable and recorded computer software for operation and maintenance of scientific apparatus, instruments and equipment; downloadable and recorded computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; digital Polymerase Chain Reaction (dPCR) instruments, namely, digital laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction (PCR); apparatus for detecting the amount of nucleic acids binding fluorescence dye or the amount of fluorescence dye released from nucleic acid binding probe for laboratory or research use; downloadable and recorded computer software and hardware for medical diagnostic instruments for digital Polymerase Chain Reaction (dPCR); ; downloadable and recorded computer software and hardware for processing diagnostic medical testing or laboratory data; computer hardware and ; downloadable and recorded software for use in laboratory management, namely, database management, experimental data management, information management; downloadable and recorded computer software and hardware for data analysis for use in laboratories; downloadable and recorded computer software and hardware for identifying and analyzing characteristics of nucleic acid sequence and nucleic acid; downloadable and recorded computer software and hardware for use in gene analysis, human identification, and microbial identification in the field of life science research and biological technology development; laboratory apparatus and instruments for gene analysis, human identification, microbial identification in the field of life science research and biological technology development; laboratory apparatus for genotyping, gene expression analysis, copy number variation, mutation detection and direct quantification of nucleic acids; scientific apparatuses, instruments and devices, as well as their parts and components, in particular microfluidic cartridges, microfluidic plates, digital Polymerase Chain Reaction (dPCR) plates, digital Polymerase Chain Reaction (dPCR) microfluidic plates, and covers for digital Polymerase Chain Reaction (dPCR) plates, that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; downloadable and recorded computer software for use in database management and electronic storage of data for scientific and medical research; downloadable and recorded computer software for scientific analysis of nucleic acids; downloadable and recorded analysis software and ; downloadable and recorded database management software for use in biopharmaceutical research; downloadable and recorded software for use in detecting cancer and infectious disease; downloadable and recorded software for use in operating digital polymerase chain reaction (dPCR) instruments; polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for the partitioning of Polymerase Chain Reaction (PCR) reactions, amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA, genotyping, gene expression analysis, mutations, and for direct quantification of nucleic acids; non-medical instruments, for marking, amplifying and quantifying of biopolymers, in particular analysis of nucleic acids, for use in Polymerase Chain Reaction (PCR) methods

Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; kits containing preparations for medical and veterinary diagnostic purposes, in particular for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; chemical reagents for medical purposes; cartridges containing medical diagnostic reagents for use in Polymerase Chain Reaction (PCR) or digital Polymerase Chain Reaction (PCR) instruments; medical diagnostic assays for testing of body samples, including bodily fluids and tissue in the detection, monitoring, and prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and clinical response; diagnostic preparations for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics

Reagents, enzymes and buffer solutions for scientific and/or medical research use for marking, amplifying and quantifying of biopolymers, in particular analysis of nucleic acids; reagents for scientific and medical research use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with marking amplifying, and quantifying /or for the analysis of biopolymers, in particular analysis of nucleic acids; reagent kits comprising biological protein, DNA primers, polymerase or buffers for scientific and medical research; chemical, biochemical and biotechnological products for commercial and scientific use, namely, buffer solutions, nucleic acids, nucleic acid derivatives and proteins for chemical analysis

Testing services, namely, quantifying DNA and RNA for medical, diagnostic and treatment purposes; rental of digital Polymerase Chain Reaction (PCR) apparatus; RNA or DNA analysis for cancer diagnosis and prognosis; medical services, in particular medical analysis in connection with the treatment of individuals; providing information in the fields of medicine, veterinary medicine and diagnostic, prophylactic and therapeutic properties of pharmaceuticals; health centers, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; medical clinics; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases; medical laboratory services for the analysis of samples taken from patients

Apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions, namely, DNA and RNA testing apparatus; medical and veterinary equipment for diagnostic purposes, in particular for processing and analysis of genetic samples, for rare genetic mutation detection, for copying of number variation analysis, for gene expression analysis, for pathogen detection, for genotyping, and for miRNA research; clinical medical laboratory apparatus and analytical instruments, namely, digital Polymerase Chain Reaction (d PCR) instruments for use in-vitro and in-vivo diagnostics; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (dPCR) platforms; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (dPCR) platform; medical devices, namely, digital polymerase chain reaction (dPCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (dPCR) platform; medical devices, namely, digital polymerase chain reaction (dPCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (dPCR) platform; microfluidic plates for use as medical apparatus

Scientific research for others in the fields of genetics, biology and biochemistry; scientific diagnostic services for others in the fields of DNA, RNA detection and analysis; scientific and research services for others utilising digital Polymerase Chain Reaction (PCR) platforms; scientific consultancy with regard to the establishment of a dPCR laboratory; research and development services in the field of bioanalytics, namely, the development of pharmaceutical, medical, forensic, veterinary and agricultural chemicals and biochemicals; genomic analysis, assaying, imaging and profiling; chemical screening analysis; genetic medical testing and analytic services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 28, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 3, 2022 FICS
FINAL DISPOSITION PROCESSED
Feb 2, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 24, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 24, 2021 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 21, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 21, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 21, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 21, 2021 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 2, 2021 TROA
CORRECTION SENT TO IB
Dec 1, 2020 CRSN
CORRECTION CREATED FOR IB
Dec 1, 2020 CRCR
REFUSAL PROCESSED BY IB
Nov 29, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 10, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 20, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 19, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 10, 2020 MAFR
ASSIGNED TO EXAMINER
Oct 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 1, 2020 REPR